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Lipoic Acid Synthetase Deficiency Causes
Neonatal-Onset Epilepsy, Defective Mitochondrial
Energy Metabolism, and Glycine Elevation
Johannes A. Mayr,1,* Franz A. Zimmermann,1 Christine Fauth,2 Christa Bergheim,3 David Meierhofer,4
Doris Radmayr,1 Johannes Zschocke,2 Johannes Koch,1 and Wolfgang Sperl1
Lipoic acid is an essential prosthetic group of four mitochondrial enzymes involved in the oxidative decarboxylation of pyruvate,
a-ketoglutarate, and branched chain amino acids and in the glycine cleavage. Lipoic acid is synthesized stepwise within mitochondria
through a process that includes lipoic acid synthetase. We identified the homozygous mutation c.746G>A (p.Arg249His) in LIAS in an
individual with neonatal-onset epilepsy, muscular hypotonia, lactic acidosis, and elevated glycine concentration in plasma and urine.
Investigation of the mitochondrial energy metabolism showed reduced oxidation of pyruvate and decreased pyruvate dehydrogenase
complex activity. A pronounced reduction of the prosthetic group lipoamide was found in lipoylated proteins.Lipoic acid, also called thioctic acid, is formed inmitochon-
dria by a series of reactions involving the mitochondrial
fatty acid synthase type II (FAS II). Via FAS II, octanoic
acid is synthesized in an acyl carrier protein (ACP)-bound
fashion. As known from studies in bacteria and yeast, octa-
noic acid is transferred from octanoyl-ACP to a target
protein.1–3 Further on, two sulfohydryl groups are intro-
duced at positions 6 and 8 on the protein-bound octanoic
acid in a stepwise and stereoselectivemanner. This reaction
is catalyzed by the enzyme lipoic acid synthetase (LIAS),
which is a highly conserved enzyme found in prokaryotes
and eukaryotes (Figure 1). In eukaryotes, lipoic acid func-
tions as a coenzyme of the threemitochondrial dehydroge-
nase complexes pyruvate dehydrogenase (PDHC), a-keto-
glutarate dehydrogenase (a-KGDH), and branched chain
keto acid dehydrogenase (BCKDH), which share a similar
architecture (three enzymatic subunits: E1, E2, and E3) ar-
ranged in an enzyme complex of high molecular weight.
Lipoic acid is bound via an amide bond to the ε-amino
group of a strictly conserved lysine of the respective E2
subunits. Furthermore, the subunit E3 binding protein of
PDHC, which resembles the E2 subunit, is also lipoy-
lated.4 In a similar fashion, lipoic acid acts as a prosthetic
groupof theHproteinof the glycine cleavage system (GCS).
LIAS-deficient Escherichia coli becomes auxotrophic for
lipoic acid, which can be taken up and metabolized via
the salvage pathway.5 In contrast, eukaryotes are strictly
dependent on the de novo synthesis of the lipoyl group
within mitochondria. This has been shown in the Saccha-
romyces cerevisiae lip5 mutant (encoding the lipoic acid
synthetase), which is unable to utilize lipoic acid supplied
in the growth medium.6 It was also found that early
embryonic lethality of LIAS knockoutmice cannot be over-
come or ameliorated by feeding of lipoic acid to pregnant
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792 The American Journal of Human Genetics 89, 792–797, DecembHere we describe a boy with early-onset lactic acidosis,
severe encephalomyopathy, and a pyruvate oxidation
defect, in whom a deficiency in lipoic acid synthesis could
be delineated as the underlying cause of the disease. The
study investigations have been conducted according to
the Austrian Gene Technology Act and comply with the
Declaration of Helsinki. The investigations are furthermore
approved by the head of the Pediatric Department and the
head of the Paracelsus Medical University.
The affected individual was the first child of consanguin-
eous Turkish parents. The pregnancy was uneventful, the
delivery was spontaneous at term, and the child had Apgar
scores of 9/10/10, an umbilical artery pH of 7.35 (normal
range: 7.18–7.38), a birth weight of 3,140 g (normal range:
2600–4300 g), a length of 52 cm (normal range: 46–55 cm),
and a head circumference of 33 cm (normal range:
32–38 cm). The first two dayswere uneventful. On the third
day of life, the first convulsions were observed. They
affected the left arm and leg and also included oral
automatisms, which lasted for approximately one minute.
The boy was admitted to the hospital on day 4 because
of the seizures. He showed muscular hypotonia and
poor sucking but did not require infusions. Seizures
were controlled by phenobarbitone. On day 8, the clinical
condition deteriorated, including recurrent apneas, re-
duced consciousness, worsened hypotonia, and an increase
of convulsions. Lactate was found to be elevated to
4.6 mmol/l (normal < 2.1 mmol/l). Antibiotic treatment
with ampicillin and gentamicin was started because of an
increase of C-reactive protein. The child became somnolent
and showed poor feeding, and lactate in his plasma
increased up to 13.0 mmol/l. On day 11, a sudden and
dramatic further deterioration occurred, including acute
respiratory deficiency and severe lactic acidosis of up
to 57.7 mmol/l (base excess 20), necessitating artificial5020, Austria; 2Department of Human Genetics, Medical University of
rienhausklinik, Neunkirchen 66539, Germany; 4Max Planck Institute for
Genetics. All rights reserved.
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Figure 1. Lipoic Acid Synthetase Catalysis the Formation of the
Protein-Bound Prosthetic Group Dihydrolipoamideventilation for 17 days. Chest X-ray revealed an infiltration
of the lungs. Sonography of the brain, which had been
normal initially, now showed severe brain edema. Selective
screening for organic and amino acids in urine revealed
moderately elevated concentrations of glutaric acid and
glycine, respectively. Glycine in plasma was elevated to
906 mmol/l (normal range: 126–384 mmol/l).
After stabilization of this severe neurometabolic crisis,
the child developed spastic tetraparesis and presented
with symptomatic epilepsy, crying attacks, poor feeding,
and lactate elevation between 5 and 7 mmol/l. Brain
sonography revealed a multicystic encephalopathy and
hydrocephalus ex vacuo. Echocardiography was per-
formed at the age of 11 months and showed a mild hyper-
trophic cardiomyopathy with mild insufficiency of the
right heart. At an age of 2 years, the boy’s motor and
mental development was severely retarded, and his disease
presentation had progressed to include spastic tetraplegia,
contractures, microcephaly, and a restless condition
including sleep disturbances. Lactate levels were reduced
to nearly normal values, with moderate intermittent eleva-
tions up to 3.5 mmol/l. At an age of 4 years, the child died
at home from a severe respiratory tract infection. The
parents had only loose contact with the local hospital
and the referring neuropediatrician. An autopsy has not
been performed.
A muscle biopsy performed at one month of age showed
normal enzyme histochemistry, and electron microscopy
revealed abnormally elongated mitochondria with an
electron-dense matrix. Respiratory chain enzymes were
normal. For reevaluation of the mitochondrial energy
metabolism, a needle biopsy of the muscle was performed
at 11 months of age. Investigation of oxidation of mito-
chondrial substrates by intact mitochondria-enriched
postnuclear supernatant from a fresh muscle biopsy8
showed a severely reduced reactivity with pyruvate-con-
taining substrates, whereas acetylcarnitine-containing
substrates were normally metabolized (Table 1). This resultThe Americanclearly indicated a defect in the mitochondrial pyruvate
oxidation route. The oxidation of acetylcarnitine þmalate
was reduced in the absence of arsenite but normal in its
presence (Table 1). Given that arsenite is an inhibitor of
a-KGDH, this result is in line with a defect of the
a-KGDH. Measurement of single enzymes of the mito-
chondrial energy metabolism9,10 showed a clearly reduced
activity of the pyruvate dehydrogenase complex, and
other enzymes were only moderately affected (Table 1).
Remarkably, immunoblot analysis11 with an antibody
cocktail against PDHC subunits (MSP02, Mitosciences)
showed only moderate changes in the protein content:
the subunits E1 a and E1 bwere found in normal amounts,
but E2 and E3 binding proteins were obviously decreased
in comparison to a control sample and were related to
the ATP synthase subunit OSCP (Figure 2). This result is
remarkable because both E2 and E3 binding protein nor-
mally carry the prosthetic group lipoic acid.
Mutations in the genes of the PDHC subunits (PDHA1
[MIM 300502], PDHB [MIM 179060], DLAT [MIM
608770], DLD [MIM 238331], and PDHX [MIM 608769]),
PDHC phosphatases (PPAPDC2 [MIM 605993], PDP2, and
PDPR), and thiamine transporters (SLC19A2 [MIM
603941], SLC19A3 [MIM 606152], and SLC25A19 [MIM
606521]) were excluded by Sanger sequencing8 and expres-
sion analysis of these genes. Because the parents were con-
sanguineous, autozygosity mapping (HumanCytoSNP-
12v1 BeadChip, Illumina) was performed in this family.
Out of seven candidate genes involved in lipoic acid
synthesis (MCAT, OXSM [MIM 610324], MECR [MIM
608205], LIPT1 [MIM 610284], LIPT2, LIAS [MIM
607031], and SLC25A26 [MIM 611037]), two localized
within the autozygous regions. Additional candidates in
this pathway, the PPTase AASDHPPT (MIM 607756), the
acyl carrier protein NDUFAB1 (MIM 603836), the possible
mtFAS II ketoreductase made up of CBR4 and HSD17B8
(MIM 601417), dehydratase RPP14 (MIM 606112), andma-
lonyl-CoA synthetase ACSF3 (MIM 614245), were consid-
ered later, but all of them lie within heterozygous regions.
Furthermore, two enzymes involved in the maturation of
the mitochondrial iron sulfur clusters have recently been
shown to result in a deficiency of LIAS,12 because LIAS
depends on iron sulfur cluster prosthetic groups.13
However, NFU1 (MIM 608100) and BOLA3 (MIM 613183)
were not within autozygous regions. Sequence analysis of
MCAT, located in a small autozygous region of chromo-
some 22 and encoding the mitochondrial malonyl
CoA:ACP acyltransferase, showed a normal result. In
contrast, a potential disease-causing mutation in LIAS, en-
coding the lipoic acid synthetase, was found to map to
a large autozygosity region of 19.7 million bases on the
short arm of chromosome 4. Sequence analysis of LIAS
(RefSeq NM_006859.2) revealed a homozygous mutation,
c.746G>A (Figure 3), in exon 8, predicted to result in a
replacement of arginine 249 by histidine (p.Arg249His).
The parents were shown to be heterozygous carriers of
this mutation. This position is highly conserved inJournal of Human Genetics 89, 792–797, December 9, 2011 793
Table 1. Investigation of the Mitochondrial Energy Metabolism in Muscle and Fibroblasts
P-LIAS Muscle Control Muscle P-LIAS Fibroblasts Control Fibroblasts
Substrate Oxidation Rates [nmol/h/mg protein]
[1 - 14C]pyruvateþmalateþADP 34 263–900
[1 - 14C]pyruvateþcarnitineþADP 35 302–856
[1 - 14C]pyruvateþmalate (ADP) 24 32–102
[U - 14C]malateþpyruvateþmalonateþADP 64 282–874
[U - 14C]malateþacetylcarn.þmalonateþADP 246 273–678
[U - 14C]malateþacetylcarn.þarseniteþADP 182 156–378
[1,4 - 14C]succinateþacetylcarnitineþADP 153 167–488
Enzyme Activities [unit/g protein]
Citrate synthase 351 150–325 286 242–590
Complex I 26 28–76 30 15–53
Complex IþIII 46 64–218 171 102–343
Complex II 23 39–102 88 103–285
Complex IIþIII 32 65–180 123 167–314
Complex III 179 351–762 262 283–1174
Cytochrome c oxidase 601 306–889 203 392–939
Oligomycin-sensitive ATPase (complex V) 199 70–397 189 36–167
Pyruvate dehydrogenase complex 0.4 6.1–19.8 0.5 6.0–19.7
Functional investigation of postnuclear supernatant prepared from native, unfrozen muscle showed reduced activities in all pyruvate-containing oxidation
reactions and was mildly reduced with malate plus pyruvate in the absence of arsenite. Analysis of respiratory chain enzymes, ATPase, and pyruvate dehydroge-
nase complex revealed strongly reduced activities of the pyruvate dehydrogenase complex in postnuclear supernatant prepared from muscle and isolated mito-
chondria from fibroblasts in the individual affected with LIAS deficiency (P-LIAS).eukaryotic and also prokaryotic lipoic acid synthetases
(Figure 3). The content of the prosthetic group lipoic acid
was investigated by either immunoblot analysis or immu-
nohistochemical staining14 with a rabbit anti-lipoic acid
polyclonal antibody (#437695, Calbiochem) using the
lipoic acid auxotrophic E. coli strain JRG33.15 Immunoblot
analysis with the lipoic acid antibody showed a severe
reduction of the intensities of the E2 subunits of both
PDHC and a-KGDH (Figure 4). Because BCKDH and the
H protein of the glycine cleavage system are expressed
mainly in the liver16,17 we were not able to show a defi-
ciency of these enzymes because only muscle and fibro-
blasts were available. Immunohistochemical staining of
fibroblasts from the affected individual confirmed a defi-
ciency of lipoic acid by showing loss of staining with the
antibody against lipoic acid in comparison to normal
staining with an anti-porin antibody (Figure 4). In order
to demonstrate the functional relevance of the mutation
p.Arg249His, we expressed either the wild-type or the
mutated human lipoic acid synthetase in the E. coli clone
JRG33, which carries the p.Glu195Lys mutation in the
endogenous LIAS gene lipA and is auxotrophic for lipoic
supplied in the growthmedium.18,19 Functional expression
of a eukaryotic LIAS in E. coli has been previously shown
for the enzyme from Arabidopsis thaliana.20 The E. coli lipA794 The American Journal of Human Genetics 89, 792–797, Decembwas cloned into the PstI site of pGEM-3Zf(þ) (Promega)
after PCR amplification from wild-type genomic DNA
with primers lipA-PstI-F 50-CGAACTGCAGTAAACCCATT
GTGATGGAAC-30 and lipA-PstI-R 50-CGAACTGCAGGAC
GCTCCCTCAATATCT-30 and digestion with PstI (Fermen-
tas). The start codon of lipA was replaced by the first 21
amino acids of lacZ. The human LIAS was amplified from
cDNA of either the affected individual or a control via
PCR with the primers LIAS-Hind-F 50-CCGCAAGCTTGC
CAGATAAAAAAAAGGAACTC-30 and LIAS-Hind-R 50-CG
GCAAGCTTGTGATCTTGAAGGTCTTGTTG-30, digested
with HindIII (New England Biolabs), and cloned into the
HindIII site of pGEM-3Zf(þ). The first 27 amino acids of
humanLIAS that arepredicted tobe amitochondrial-target-
ing sequence were replaced by the first 15 amino acids of
lacZ. The constructs were transformed into JRG33 carrying
thepREP4plasmid (QIAGEN) andexpressed in thepresence
of 0.2 mmol/l isopropyl b-D-1-thiogalactopyranoside
(IPTG). As shown in Figure 5, there was no difference in
growth between the wild-type and the mutant human
LIAS when grown in the presence of lipoic acid in the
medium but there was an obvious growth defect in the
mutant cells when grown in the absence of lipoic acid.
Here, we describe an individual with a defect in
the synthesis of the prosthetic group lipoic acid. Thiser 9, 2011
Affected
individual
Parents
Control
Affected individual       H
H. sapiens      ETVPELQSKVRDPRANFDQSL 259
M. musculus     ETVPELQRKVRDPRANFDQSL 258
D. melanogaster ETVEKLTPYVRDRRAHYRQTL 256
S. cerevisiae   ETVESLTPHVRDRRATYRQSL 303
A. thaliana     ETVKRLQRLVRDPRAGYEQSM 280
E. coli         ENVPRIYRQVR-PGADYNWSL 215
St. aureus      ETVRRLTPRVR-ARATYDRTL 206
C. pseudotub.   ETVPRIFKRIR-PAFRYERSL 201
Consensus        *.*  :   :*     :  ::
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Figure 3. Mutation Analysis of LIAS
Sequence analysis (A) revealed the mutation c.746G>A
(p.Arg249His) in LIAS, which affects a phylogenetically conserved
amino acid (B).
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Figure 2. Immunoblot Analysis of PDHC Subunits
Immunoblot analysis with an antibody cocktail against subunits
of the pyruvate dehydrogenase complex performed with samples
of muscle from the affected individual showed a decrease of E2
and E3 subunit binding protein, whereas the subunits E1a and
E1b were found in normal amounts in comparison to the subunit
OSCP of the ATP synthase.deficiency was identified during in-depth investigations of
a group of so-far-unresolved cases of individuals suspected
to have disorders in the mitochondrial energy metabolism
and defects in the oxidation of pyruvate. Because genetic
investigation of subunit genes of either PDHC or its phos-
phatases did not reveal any conclusive abnormalities, we
considered defects in the metabolism of PDHC cofac-
tors.21 Elevation of glycine in the diseased individual was
a clue for the affection of lipoic acid metabolism because
this cofactor is also needed for glycine cleavage. SNP array
analysis in this consanguineous family showed, among
others, a homozygous region on chromosome 4, which
contained LIAS, the gene of the lipoic acid synthetase,
a candidate gene that turned out to be affected in this
individual.
Lipoic acid is needed exclusively in mitochondria and
is required for the enzyme reactions of the three keto
acid dehydrogenases PDHC, a-KGDH, and BCKDH as
well as the glycine cleavage system. The defect of the
lipoic acid synthetase resulted in lactic acidosis and
glycine elevation, the former reflecting the defects within
the mitochondrial energy metabolism and the latter re-
flecting the defect in the glycine cleavage system.
Remarkably, there was no documented elevation of the
branched chain amino acids leucine, isoleucine, valine,
or even allo-isoleucine in the investigation of amino
acids in plasma, in spite of a possible affection of
BCKDH. However, the relative concentrations of these
amino acids had not been studied systematically in the
affected individual, and because the branched chain
amino acids are essential amino acids, the concentration
of these metabolites depends on the nutritional supply at
the time of investigation. Normal results of branchedThe Americanchain amino acids can be found in individuals with
maple syrup urine diseases (MIM 248600).22 It therefore
remains open whether a disturbance of branched chain
amino acid metabolism contributes to the biochemical
and clinical phenotype of disorders in the synthesis of
lipoic acid.
The clinical course in the individual with lipoic acid
synthetase deficiency was characterized by a severe meta-
bolic crisis with hyperlactatemia and severe convulsions
within the first weeks of life. The severe deterioration
including massive metabolic acidosis and brain edema
was devastating and led to a secondary cystic encephalop-
athy. Therefore, the clinical course after this crisis was
superposed by this severe brain damage.
Given that the deficiency in lipoic acid affects different
metabolic pathways, it can be speculated which of
them is clinicallymost relevant. Neonatal seizures are char-
acteristic for severe forms of nonketotic hyperglycinemiaJournal of Human Genetics 89, 792–797, December 9, 2011 795
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Figure 4. Immunoblot Analysis and Immunoflorescence Stain-
ing of Lipoic Acid
Immunoblot analysis with an antibody against lipoic acid (A)
showed a severe decrease of the E2 subunits of both PDHC and
a-KGDH in the affected individual (P-LIAS) in comparison to
control muscle. Subunit OSCP of the ATP synthase (B) was used
as a loading control. Immunocytochemical staining of fibroblasts
showed a decreased staining with the antibody against lipoic
acid (red) compared to porin (green) in cells from the affected
individual (C) compared to the control (D).(NKH [MIM 605899])23 but can also be found in individ-
uals with mitochondrial encephalopathies, including
PDHC deficiency.24,25 Cardiac involvement, as found in
the LIAS-deficient individual, is an unusual finding in
NKH26 as well as in PDHC deficiency. Given that the heart
is adapted to use fat rather than glucose as an energy
source, it is comprehensible that the heart is not affected
in individuals with deficiency of PDHC, an enzyme that
is not necessary for fatty acid oxidation. The Krebs cycle,
however, is necessary for acetyl-coenzyme A oxidation,
and therefore a-KGDH is likely to be important for the
cardiac energy metabolism. Isolated metabolic defects of
a-KGDH have not been identified so far. However, in three796 The American Journal of Human Genetics 89, 792–797, Decembindividuals with amutation in dihydrolipoamide dehydro-
genase (DLD, E3 subunit) and predominant deficiency of
a-KGDH, two of the individuals suffered from hypertro-
phic cardiomyopathy.27
The synthesis of lipoic acid involves several enzymatic
steps and depends on the mitochondrial fatty synthesis
(FAS II)1–3 and iron sulfur cluster biosynthesis.12 We
hypothesize that defects in any of these steps might
result in a similar biochemical and clinical phenotype.
From the experience of the individual with LIAS defi-
ciency, we conclude that in individuals with suspect
mitochondrial encephalomyopathy, especially with
neonatal-onset lactic acidosis, unclear pyruvate oxidation
deficiency, and glycine elevation, a defect in the lipoic
acid metabolism should be considered. Determination
of the function of the lipoic acid prosthetic group can
be performed in fibroblasts and muscle biopsies, either
by immunoblotting or by quantification of the hydro-
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OMIM (Online Mendelian Inheritance in Man): http://www.
omim.orgFigure 5. Lipoic Acid Synthetase Complemen-
tation Analysis in Escherichia coli
Complementation analysis in the lipoic acid
synthetase-deficient E. coli strain JRG33 revealed
a clear growth retardation on lipoic acid-free
growth medium19 (A and C) of cells expressing
the mutant (LIAS-mut) versus the wild-type
(LIAS-wt) human LIAS. The strain that expressed
the E. coli wild-type lipA grew at a rate similar to
that expressing the wild-type human LIAS,
whereas there was no growth with the empty
vector (vector). Fast growth was observed with
all constructs on the same medium when supple-
mented with 1 ng/l lipoic acid (B and D).
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